![AbCellera Biologics Inc](/common/images/company/N_ABCL.png)
AbCellera Biologics Inc (ABCL)
NASDAQ
Fin d'année 31 Décembre 2023 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | 23.653 | 13.206 | 11.087 | -9.666 |
Return on Equity (%) | 28.637 | 16.535 | 14.034 | -12.273 |
Return on Invested Capital (%) | 41.282 | 21.901 | 18.908 | -19.036 |
Operating Margin (%) | 70.487 | 59.801 | 50.089 | -457.67 |
Net Profit Margin (%) | 51.004 | 40.902 | 32.656 | -385.005 |
Book Value Per Share | 2.538 | 2.917 | 3.624 | 3.337 |
Earnings Per Share | 0.441 | 0.54 | 0.545 | -0.496 |
Cash Per Share | 2.205 | 1.675 | 1.329 | 0.452 |
Working Capital Per Share | 2.634 | 2.846 | 3.12 | 2.553 |
Operating Profit Per Share | 0.865 | 1.32 | 1.669 | 0.129 |
EBIT Per Share | 0.586 | 0.771 | 0.822 | -0.59 |
EBITDA Per Share | 0.586 | 0.771 | 0.822 | -0.59 |
Free Cash Flow Per Share | 0.476 | 0.685 | 0.681 | -0.338 |
Fin d'année 31 Décembre 2023 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A |
Actions en circulation | 269,5M | 283,26M | 286,85M | 290,82M |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | |||||
Actions en circulation | 286,85M | 288,43M | 289,19M | 289,78M | 290,82M | 293,62M | 294,67M | 295,16M |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | -394.915 | N/A | N/A | N/A | -429.445 | N/A | N/A |
Net Profit Margin (%) | N/A | -328.986 | N/A | N/A | N/A | -407.977 | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 969,45M |
Ratio cours/bénéfice | -6,26 |
Ratio prix/ventes | 24,11 |
Ratio prix/liquidités | 6,87 |
Ratio prix/valeur comptable | 0,8 |
Rendement de dividende | - |
Actions en circulation | 294,67M |
Volume moyen (1 semaine) | 3,17M |
Volume moyen (1 mois) | 3,89M |
Variation sur 52 semaines | -40,73% |
Plus haut sur 52 semaines | 5,46 |
Plus bas sur 52 semaines | 2,335 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales